Pfizer Inc (PFE)

$26.58 -0.28 (-1.04%)
Market Cap 152.73B
Revenue (ttm) 62.58B
Net Income (ttm) 7.77B
EPS (ttm) N/A
PE Ratio 8.45
Forward PE 9.18
Profit Margin 12.42%
Debt to Equity Ratio 0.75
Volume 34,270,800
Avg Vol 46,431,367
Day's Range N/A - N/A
Shares Out 5.69B
Stochastic %K 31%
Beta 0.47
Analysts Sell
Price Target $28.82

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
Blizzy
Blizzy Mar. 14 at 6:21 AM
$PFE still hadn’t broken $28 🤷🏻‍♂️🤦🏻‍♂️🤣
0 · Reply
RobertOppegard534
RobertOppegard534 Mar. 14 at 5:10 AM
$PFE pharmaceutical company Pfizer
0 · Reply
History101
History101 Mar. 13 at 10:31 PM
$PFE https://substack.com/@stopthoseshots/note/c-227205977?r=re3i2&utm_medium=ios&utm_source=notes-share-action
0 · Reply
Micheal_Pothead
Micheal_Pothead Mar. 13 at 7:59 PM
$PFE -2.5% from todays high on 1/2 average daily volume cheers
0 · Reply
Micheal_Pothead
Micheal_Pothead Mar. 13 at 7:41 PM
$PFE why wouldn’t it be a sell off into close
0 · Reply
doubleuptwice
doubleuptwice Mar. 13 at 7:22 PM
$PFE hey we’re up 7% ytd and we didn’t break structure today on an ugly market . I’ll count that as a win
0 · Reply
Cathwoodie
Cathwoodie Mar. 13 at 5:46 PM
$NVS Breaking news 🚨 COSENTYX GETS FDA APPROVAL FOR KIDS WITH HS $PFE $MRNA
0 · Reply
Micheal_Pothead
Micheal_Pothead Mar. 13 at 4:46 PM
$PFE LLY is green 🎉
1 · Reply
DragonAlgo
DragonAlgo Mar. 13 at 4:32 PM
🐉 $PFE PUT — DragonAlgo® Signal Contract: PFE PUT Expiry: 2026-03-20 | Strike: $26.50 | Type: PUT Option Plan (premium): Entry: $0.30 Stop: $0.22 TP1: $0.40 TP2: $0.52 TP3: $0.73 🔗 https://dragonalgo.com
0 · Reply
dom04
dom04 Mar. 13 at 4:01 PM
$PFE someone tired of trading... 10M volume... as boring as it could get...
0 · Reply
Latest News on PFE
Expect Pfizer To Comeback: Take The Dividend While Waiting For Capital Appreciation

Mar 13, 2026, 5:01 PM EDT - 9 hours ago

Expect Pfizer To Comeback: Take The Dividend While Waiting For Capital Appreciation

Pfizer's eczema drug meets main goal in mid-stage trial, plans late-stage study

Mar 9, 2026, 7:27 AM EDT - 4 days ago

Pfizer's eczema drug meets main goal in mid-stage trial, plans late-stage study

Pfizer's Phase 2 Study of Trispecific Antibody Positive in Moderate to Severe Atopic Dermatitis

Mar 9, 2026, 6:45 AM EDT - 4 days ago

Pfizer's Phase 2 Study of Trispecific Antibody Positive in Moderate to Severe Atopic Dermatitis

5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 8% (March 2026)

Mar 7, 2026, 8:15 AM EST - 6 days ago

5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 8% (March 2026)

ADP ARCC BX CAG GLPI MPLX MSFT

Wall Street Breakfast Podcast: India To Buy Russian Oil As War Disrupts Supplies

Mar 6, 2026, 6:05 AM EST - 7 days ago

Wall Street Breakfast Podcast: India To Buy Russian Oil As War Disrupts Supplies

AMD GOOG GOOGL LLY NVDA NVO

China approves Pfizer GLP-1 drug for weight management

Mar 6, 2026, 12:40 AM EST - 8 days ago

China approves Pfizer GLP-1 drug for weight management

Judge approves Pfizer, SEC settlement tied to insider trading at Cohen hedge fund

Mar 5, 2026, 4:48 PM EST - 8 days ago

Judge approves Pfizer, SEC settlement tied to insider trading at Cohen hedge fund

Seven S&P500 Ideal 'Safer' March Dividend Dogs

Mar 4, 2026, 11:31 AM EST - 9 days ago

Seven S&P500 Ideal 'Safer' March Dividend Dogs

AMCR ARE BBY BEN BXP CAG CCI

Pfizer's Portfolio Renewal In Progress - High Yields For The Patient

Mar 4, 2026, 9:09 AM EST - 9 days ago

Pfizer's Portfolio Renewal In Progress - High Yields For The Patient

NYSE Content Update: Alysa Liu Rings NYSE Bell After Winning Two Gold Medals

Mar 4, 2026, 8:55 AM EST - 9 days ago

NYSE Content Update: Alysa Liu Rings NYSE Bell After Winning Two Gold Medals

SMWB

Pfizer's Quiet Cash Comeback

Mar 3, 2026, 9:50 AM EST - 10 days ago

Pfizer's Quiet Cash Comeback

Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 4% Dividend Yields

Mar 3, 2026, 8:10 AM EST - 10 days ago

Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 4% Dividend Yields

PRGO XRAY

Pfizer Inc. (PFE) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Mar 2, 2026, 1:27 PM EST - 11 days ago

Pfizer Inc. (PFE) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Pfizer CEO flags issues with FDA's vaccine leadership

Mar 2, 2026, 11:14 AM EST - 11 days ago

Pfizer CEO flags issues with FDA's vaccine leadership

The High Dividend Yield Bull Market: 3 Compelling 6% Yields

Mar 2, 2026, 4:51 AM EST - 11 days ago

The High Dividend Yield Bull Market: 3 Compelling 6% Yields

ABBV AMGN AVGO BTI DIV ENB GTY

14 Ideal 'Safer' Dividend Buys From 29 Of 69 March Graham Value All-Stars (GVAS)

Mar 1, 2026, 8:10 AM EST - 12 days ago

14 Ideal 'Safer' Dividend Buys From 29 Of 69 March Graham Value All-Stars (GVAS)

ARCC BBVA E EQNR ETD FINV GSL

PADCEV™ + Keytruda® Cuts Risk of Recurrence or Death by Nearly 50% in Cisplatin-Eligible Muscle-Invasive Bladder Cancer

Feb 27, 2026, 10:00 AM EST - 14 days ago

PADCEV™ + Keytruda® Cuts Risk of Recurrence or Death by Nearly 50% in Cisplatin-Eligible Muscle-Invasive Bladder Cancer

5 'Safer' Dividend Buys In Barron's 23 Better February Bets Than T-Bills

Feb 26, 2026, 7:48 AM EST - 15 days ago

5 'Safer' Dividend Buys In Barron's 23 Better February Bets Than T-Bills

BBY CAG EQR FRT KEY KMI LYB

U.S. FDA Grants Full Approval to Pfizer's BRAFTOVI Combination Regimen in First-Line Metastatic Colorectal Cancer

Feb 24, 2026, 2:29 PM EST - 17 days ago

U.S. FDA Grants Full Approval to Pfizer's BRAFTOVI Combination Regimen in First-Line Metastatic Colorectal Cancer

Pfizer Adds Sciwind As China Partner For New Weight Loss Drug

Feb 24, 2026, 7:45 AM EST - 17 days ago

Pfizer Adds Sciwind As China Partner For New Weight Loss Drug

Pfizer in diabetes drug deal with Sciwind Biosciences

Feb 23, 2026, 10:26 PM EST - 18 days ago

Pfizer in diabetes drug deal with Sciwind Biosciences

US FDA Commissioner Makary says FDA supports mRNA vaccines but US taxpayers should not bear the cost

Feb 23, 2026, 3:15 PM EST - 18 days ago

US FDA Commissioner Makary says FDA supports mRNA vaccines but US taxpayers should not bear the cost

MRK MRNA

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Feb 23, 2026, 10:00 AM EST - 18 days ago

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Pfizer: A Risky 6.3% Yield For Income-Oriented Investors

Feb 20, 2026, 11:47 PM EST - 21 days ago

Pfizer: A Risky 6.3% Yield For Income-Oriented Investors

Is There 25% Downside For Pfizer Stock?

Feb 18, 2026, 12:00 PM EST - 23 days ago

Is There 25% Downside For Pfizer Stock?

Pfizer: Recovery Isn't Over, Battered Valuation Still Discounts Its Turnaround Game

Feb 18, 2026, 11:30 AM EST - 23 days ago

Pfizer: Recovery Isn't Over, Battered Valuation Still Discounts Its Turnaround Game

Pfizer: The Rebound Looks Unsustainable

Feb 17, 2026, 5:42 PM EST - 24 days ago

Pfizer: The Rebound Looks Unsustainable

Pfizer's BRAFTOVI Regimen Improves Progression-Free Survival in Metastatic Colorectal Cancer

Feb 17, 2026, 6:45 AM EST - 24 days ago

Pfizer's BRAFTOVI Regimen Improves Progression-Free Survival in Metastatic Colorectal Cancer

Prices, pipelines and patent cliffs: Inside pharma's big reset

Feb 13, 2026, 6:13 AM EST - 4 weeks ago

Prices, pipelines and patent cliffs: Inside pharma's big reset

AMGN LLY NVO

These 32 favorite stocks signal the bull market is running on fumes

Feb 12, 2026, 8:05 AM EST - 4 weeks ago

These 32 favorite stocks signal the bull market is running on fumes

AAPL ABT ADBE AMGN AVGO BAC BK

Pfizer: A Great Opportunity Post Earnings

Feb 11, 2026, 6:08 PM EST - 4 weeks ago

Pfizer: A Great Opportunity Post Earnings

2 Urgent Sells And 2 No Brainer Dividend Buys

Feb 11, 2026, 4:06 PM EST - 4 weeks ago

2 Urgent Sells And 2 No Brainer Dividend Buys

ABBV AEP AMGN BMY ESS HASI HD

Is Pfizer Stock Now A Value Trap?

Feb 11, 2026, 8:56 AM EST - 4 weeks ago

Is Pfizer Stock Now A Value Trap?

Pfizer to collect $29 million from SEC case against Steven A. Cohen hedge fund

Feb 10, 2026, 3:20 PM EST - 4 weeks ago

Pfizer to collect $29 million from SEC case against Steven A. Cohen hedge fund

Pfizer: 'Hold' As Patent Cliff Looms, Along With Need For Differentiating Factor In Obesity

Feb 8, 2026, 10:19 PM EST - 4 weeks ago

Pfizer: 'Hold' As Patent Cliff Looms, Along With Need For Differentiating Factor In Obesity

Healthy Returns: Pfizer execs chart out obesity strategy after encouraging drug data

Feb 6, 2026, 2:55 PM EST - 5 weeks ago

Healthy Returns: Pfizer execs chart out obesity strategy after encouraging drug data

14 Ideal 'Safer' Dividend Buys From 29 Of 69 February Graham Value All-Stars (GVAS)

Feb 6, 2026, 7:25 AM EST - 5 weeks ago

14 Ideal 'Safer' Dividend Buys From 29 Of 69 February Graham Value All-Stars (GVAS)

ARCC ARLP CNQ EPD EQNR F FINV

FDA Grants Priority Review for HYMPAVZI® (marstacimab) sBLA for the Treatment of Two Hemophilia A or B Patient Populations with Significant Medical Need

Feb 6, 2026, 6:45 AM EST - 5 weeks ago

FDA Grants Priority Review for HYMPAVZI® (marstacimab) sBLA for the Treatment of Two Hemophilia A or B Patient Populations with Significant Medical Need

Pfizer Launches Cost Savings Program on TrumpRx Lowering Drug Costs for Millions of Americans

Feb 5, 2026, 7:09 PM EST - 5 weeks ago

Pfizer Launches Cost Savings Program on TrumpRx Lowering Drug Costs for Millions of Americans

Pfizer Inc. (PFE) Q4 2025 Earnings Call Transcript

Feb 3, 2026, 3:00 PM EST - 5 weeks ago

Pfizer Inc. (PFE) Q4 2025 Earnings Call Transcript

Pfizer: Messy Q4 Earnings Mask An Improving Business

Feb 3, 2026, 2:02 PM EST - 5 weeks ago

Pfizer: Messy Q4 Earnings Mask An Improving Business

Obesity stocks slump on Novo's underwhelming 2026 sales forecast

Feb 3, 2026, 1:27 PM EST - 5 weeks ago

Obesity stocks slump on Novo's underwhelming 2026 sales forecast

ALT AMGN GPCR LLY NVO VKTX

Silver Surges Over 15%; Pfizer Earnings Top Views

Feb 3, 2026, 12:00 PM EST - 5 weeks ago

Silver Surges Over 15%; Pfizer Earnings Top Views

Pfizer Q4 Earnings Review: This Classic Value Trap Remains As Tempting As Ever

Feb 3, 2026, 11:56 AM EST - 5 weeks ago

Pfizer Q4 Earnings Review: This Classic Value Trap Remains As Tempting As Ever

Pfizer, Merck report Q4 results: Citi's Geoff Meacham on key takeaways

Feb 3, 2026, 11:17 AM EST - 5 weeks ago

Pfizer, Merck report Q4 results: Citi's Geoff Meacham on key takeaways

MRK

Pfizer beats quarterly estimates despite Covid product decline - reaffirms modest outlook

Feb 3, 2026, 10:15 AM EST - 5 weeks ago

Pfizer beats quarterly estimates despite Covid product decline - reaffirms modest outlook

Pfizer's Newly Acquired Drug Shows Weight Loss Of Just Around 13%, Stock Drops

Feb 3, 2026, 8:50 AM EST - 5 weeks ago

Pfizer's Newly Acquired Drug Shows Weight Loss Of Just Around 13%, Stock Drops

Pfizer maps post-Covid reset with obesity trials and deep cost cuts

Feb 3, 2026, 8:17 AM EST - 5 weeks ago

Pfizer maps post-Covid reset with obesity trials and deep cost cuts

Pfizer says once-a-month weight-loss drug works as it forecasts profit decline

Feb 3, 2026, 7:28 AM EST - 5 weeks ago

Pfizer says once-a-month weight-loss drug works as it forecasts profit decline

Pfizer Sales Fall on Continued Lower Covid-19 Drug Demand

Feb 3, 2026, 7:21 AM EST - 5 weeks ago

Pfizer Sales Fall on Continued Lower Covid-19 Drug Demand

Blizzy
Blizzy Mar. 14 at 6:21 AM
$PFE still hadn’t broken $28 🤷🏻‍♂️🤦🏻‍♂️🤣
0 · Reply
RobertOppegard534
RobertOppegard534 Mar. 14 at 5:10 AM
$PFE pharmaceutical company Pfizer
0 · Reply
History101
History101 Mar. 13 at 10:31 PM
$PFE https://substack.com/@stopthoseshots/note/c-227205977?r=re3i2&utm_medium=ios&utm_source=notes-share-action
0 · Reply
Micheal_Pothead
Micheal_Pothead Mar. 13 at 7:59 PM
$PFE -2.5% from todays high on 1/2 average daily volume cheers
0 · Reply
Micheal_Pothead
Micheal_Pothead Mar. 13 at 7:41 PM
$PFE why wouldn’t it be a sell off into close
0 · Reply
doubleuptwice
doubleuptwice Mar. 13 at 7:22 PM
$PFE hey we’re up 7% ytd and we didn’t break structure today on an ugly market . I’ll count that as a win
0 · Reply
Cathwoodie
Cathwoodie Mar. 13 at 5:46 PM
$NVS Breaking news 🚨 COSENTYX GETS FDA APPROVAL FOR KIDS WITH HS $PFE $MRNA
0 · Reply
Micheal_Pothead
Micheal_Pothead Mar. 13 at 4:46 PM
$PFE LLY is green 🎉
1 · Reply
DragonAlgo
DragonAlgo Mar. 13 at 4:32 PM
🐉 $PFE PUT — DragonAlgo® Signal Contract: PFE PUT Expiry: 2026-03-20 | Strike: $26.50 | Type: PUT Option Plan (premium): Entry: $0.30 Stop: $0.22 TP1: $0.40 TP2: $0.52 TP3: $0.73 🔗 https://dragonalgo.com
0 · Reply
dom04
dom04 Mar. 13 at 4:01 PM
$PFE someone tired of trading... 10M volume... as boring as it could get...
0 · Reply
PFElinepfrenzy1990
PFElinepfrenzy1990 Mar. 13 at 3:56 PM
$PFE - Eepy red
0 · Reply
Micheal_Pothead
Micheal_Pothead Mar. 13 at 3:30 PM
$PFE total joke of a market today
1 · Reply
MiraPreston
MiraPreston Mar. 13 at 3:10 PM
$PFE slow money setup and this likely needs stronger accumulation before the tape cares again
0 · Reply
falcon_trader11
falcon_trader11 Mar. 13 at 2:18 PM
$HYFT announced its first recurring enterprise LensAI SaaS deal with its largest AI client. CEO said the client struggled with the same programs for 10+ years, tried multiple AI/CRO providers, and HYFT stepped in with a “no results, no pay” model. After winning 7–10 programs, the client upgraded to a 1-year LensAI platform license. Interesting timing as Pfizer ($PFE) just announced it is shutting down Pfizer Ignite, shifting away from internal incubation toward external AI platforms. $PFE could be a strong possible fit.
1 · Reply
Micheal_Pothead
Micheal_Pothead Mar. 13 at 2:18 PM
$PFE yes go red why not
0 · Reply
Micheal_Pothead
Micheal_Pothead Mar. 13 at 2:04 PM
$PFE typical lol
1 · Reply
dom04
dom04 Mar. 13 at 2:03 PM
$PFE boring day which will close at 27$
0 · Reply
stwit18
stwit18 Mar. 13 at 1:25 PM
$PFE https://rumble.com/shorts/v771dai
0 · Reply
AcedOption
AcedOption Mar. 13 at 1:00 PM
$BABA $BIDU $NVO $PFE Bounce coming soon. Bad time to sell options
1 · Reply
NomadicOptionSeller
NomadicOptionSeller Mar. 13 at 12:11 PM
$PFE $C $PFE is giving me major $C vibes from 2023. When $C was in the $40S: Analysts hated it. Sentiment was awful. Dividend was massive. Then it broke the wedge and started its move. And right now… $PFE looks very similar and has similar hatred
0 · Reply
NomadicOptionSeller
NomadicOptionSeller Mar. 13 at 12:00 PM
$BABA $NVO $BIDU $PFE Here’s 5 value stocks that pay attractive options premium and at safe price levels to WHEEL
4 · Reply
JBS_84
JBS_84 Mar. 13 at 7:03 AM
$PFE 27 tomorrow
0 · Reply